arrow
J

Joseph Vijai

memorial sloan kettering cancer center
H指数:63
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

多群体全基因组关联研究荟萃分析鉴定膀胱癌易感位点并突出吸烟相关风险的遗传调控

2026-08-080
OA
Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees

基于全外显子组测序的骨髓瘤(MM)和意义未明单克隆丙种球蛋白病(MGUS)家系的连锁分析

2025-11-100
OAAI
Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses

遗传决定的体质指数与多基因和孟德尔随机化分析中的弥漫性大B细胞淋巴瘤相关。

2025-09-050
OAAI
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy

种系遗传变异影响克隆造血景观和发展为恶性肿瘤

2025-07-150
OAAI
Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors

将所有祖先的多基因评分与传统危险因素相结合的临床乳腺癌风险评估工具的验证

2024-07-012
OAAI
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma
2023-11-234
OAAI
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes (vol 36, pg 2835, 2023)

确定了常见非霍奇金淋巴瘤亚型的不同种系遗传易感性谱 (第36卷,2835页,2023页)

LEUKEMIA
IF13.4
2023-09-040
OA
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

膀胱癌的全基因组关联研究揭示了新的生物学和转化见解

2023-07-0124
PRE
Pathogenic germline mutations and risk of multiple myeloma
2023-04-041
PRE
Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 women
2023-03-010
PRE
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer

前列腺癌仅肿瘤测序后基于基因的验证性种系检测

2023-01-019
OA
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

常见非霍奇金淋巴瘤亚型的不同种系遗传易感性特征

LEUKEMIA
IF13.4
2022-10-2212
OA
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort
2022-09-0129
OA
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer
2022-07-147
OAAI
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2022-04-2718
OA
Inherited TP53 Variants and Risk of Prostate Cancer
2022-03-0147
OA
Integration of an ancestrally unbiased polygenic risk score with the Tyrer-Cuzick breast cancer risk model
2022-02-150
PRE